REFERENCES

References - Magnetic Drug Targeting

Alexiou C. et al. Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur. Biophys J. 2006; 35: 446-450.

Alexiou C., Arnold W., Hulin P., Klein R.J., Renz H., Parak F.G., Bergemann C., Lübbe A.S. Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting. J. of Magnetism and Magnetic Materials 2001; 225: 187-193.

Alexiou C., Schmidt A., Klein R., Hulin P., Bergemann C., Arnold W. Magnetic drug targeting: biodistribution and dependency om magnetic field strength. J. of Magnetism and Magnetic Materials 2002; 252: 363-366.

Alexiou C., Arnold W., Klein R.J., Parak F.G., Hulin P., Bergemann C., Erhardt W., Wagenpfeil S., Lübbe A.S. Locoregional Cancer Treatment with Magnetic Drug Targeting. Cancer Research 2000; 60: 6641-6648.

Alexiou C., Schmid R., Jurgons R., Bergemann C., Arnold W., Parak F.G. Targeting Tumor Therapy with Magnetic Drug Targeting: Therapeutic Efficacy of Ferrofluid Bound Mitoxantrone, in: S. Odenbach (Eds.), Ferrofluids: Magnetically Controllable Fluids and Their Applications. Springer Verlag, Berlin, 2002.

Alexiou C., Arnold W., Hulin P., Klein R., Schmidt A., Bergemann C., Parak F.G. Therapeutic Efficacy of Ferrofluid Bound Anticancer Agent. Magnetohydrodynamics 2001; 37: 318-322.

Alexiou C., Jurgons R., Schmid R. J., Bergemann C., Henke J., Erhardt W., Huenges E. and Parak F. Magnetic Drug Targeting-Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment. J. Drug Targeting 2003; 11(3): 139-149.

Alexiou C., Jurgons R., Schmid R., Hilpert A., Bergemann C., Parak F. and Iro H. In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles. J. of Magnetism and Magnetic Materials 2005; 293: 389-393.

Babincova M., Babinec P. and Bergemann C. High-Gradient Magnetic Capture of Ferrofluids: Implications for Drug Targeting and Tumor Embolization. Z. Naturforsch. 2001; 56c: 909-911.

Babincova M., Altanerova V., Altaner C., Cicmanec P. and Babinec P. In vivo heating of magnetic nanoparticles in alternating magnetic field. Med. Phys. 2004; 31 (8): 2219-2221.

Dames P., Gleich B., Flemmer A., Hajek K., Seidl N., Wiekhorst F., Eberbeck D., Bittmann I., Bergemann Ch., Weyh T., Trahms L., Rosenecker J. and Rudolph C. Targeted delivery of magnetic aerosol droplets to the lung. Nature Nanotechnology August 2007; 2 (8): 495-499.

Dandamudi S. and Campbell R.B. The drug loading, cytotoxicity and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials 2007; 28 (31): 4673-4683.

Flores G. A. & Liu J. In-vitro Blockage of a Simulated Vascular System Using Magnetorheological Fluids as a Cancer Therapy. European Cells and Materials 2002; 3(2): 9-11.

Hilger I., Frühauf K., Andrä W., Hiergeist R., Hergt R., Kaiser W. A. Heating Potential of Iron Oxides for Therapeutic Purposes in Interventional Radiology. Acad Radiol 2002; 9: 198-202.

Hilger I., Andrä W., Hiergeist R., Hergt R., Schubert H., Kaiser W. A. Electromagnetic Heating of Breast Tumors in Interventional Radiology: In Vitro and in Vivo Studies in Human Cadavers and Mice. Radiology 2001; 218: 570-575.

Lemke A.-J., Senfft von Pilsach M.-I., Lübbe A., Bergemann C. et al. MRI after magnetic drug targeting in patients with advanced solid malignant tumors. Eur. Radiology 2004; 14: 1949-1955.

Lübbe A.S., Bergemann C. et al. Clinical Experiences with Magnetic Drug Targeting: A Phase I Study with 4'-Epidoxorubicin in 14 Patiens with Advanced Solid Tumors. Cancer Research 1996; 56: 4686-4693.

Lübbe A.S., Bergemann C., Brock J., McClure D.G. Physiological aspects in magnetic drug targeting. J. of Magnetism and Magnetic Materials 1999; 194: 149-155.

Lübbe A.S., Bergemann C. and Alexiou C. Magnetically-controlled Drug Targeting for cancer treatment. Recent Res. Devel. Cancer 2000; 2: 183-191.

Lübbe A.S. and Bergemann C. Editorial Magnetically-controlled drug targeting. The Cancer J. 1998; 11: n° 3.

Lübbe A.S., M.D., Ph.D., Alexiou C. and Bergemann C. Clinical Applications of Magnetic Drug Targeting. J. of Surgical Res. 2001; 95: 200-206.

Lübbe A.S., Bergemann C. and Alexiou C. Targeting Tumors with Magnetic Drugs, in: M. Pagé (Eds.), Cancer Drug Discovery and Development: Tumor Targeting in Cancer Therapy. Humana Press Inc. Totowa, New York, 2002.

Lübbe A.S. and Bergemann C. Selected Preclinical and First Clinical Experiences with Magnetically Targeted 4'-Epidoxorubicin in Patients with Advanced Solid Tumors. In: Häfeli et al. (Eds.), Scientific and Clinical Applications of Magnetic Carriers, Plenum Press, New York, 1997.

Lübbe A.S., Bergemann C. et al. Preclinical Experiences with Magnetic Drug Targeting: Tolerance and Efficacy. Cancer Research 1996; 56: 4694-4701.

Shapiro B., Probst R., Potts H.E., Diver D.A. and Lübbe A.S. Control to Concentrate Drug-Coated Magnetic Particles to Deep-Tissue Tumors for Targeted Cancer Chemotherapy. in press 2007

Steinfeld U., Pauli Ch., Kaltz N., Bergemann Ch. and Lee Hyeck-Hee. T-lymphocytes as potential therapeutic drug carrier for cancer treatment. Int. J. of Pharmaceutics 2006; 311: 229-236.

References - Magnetofection™

Baer K., Bürli T., Huh K-H, Wiesner A., Erb-Vögtli S., Göckeritz-Dujmovic D., Moransard M., Nishimune A., Rees M.I., Henley J.M., Fritschy J-M and Fuhrera C. PICK1 interacts with α7 neuronal nicotinic acetylcholine receptors and controls their clustering. Mol. Cell. Neurosci. 2007; 35: 339–355.

Basile J.R., Holmbeck K., Bugge T.H. and Gutkind J.S. MT1-MMP Controls Tumor-induced Angiogenesis through the Release of Semaphorin 4D. J. of Biolog. Chem. 2007; 282 (9): 6899–6905.

Basile J. R.,Talayeh Afkhami and J. Silvio Gutkind. Semaphorin 4D/Plexin-B1 Induces Endothelial Cell Migration through the Activation of PYK2, Src, and the Phosphatidylinositol 3-Kinase–Akt Pathway. Molecular and Cellular Biology 2005; 25 (16): 6889–6898.

Basile J. R., Rogerio M. Castilho, Vanessa P. Williams and J. Silvio Gutkind. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. PNAS 2006; 103 (24): 9017-9022.

Bridell H. Magnetic field guided nucleic acid delivery to target the Raf-1 kinase in human umbilical vein endothelial cells. Master thesis in medical science 2003, Technical University of Munich, Germany.

Buerli T., Pellegrino C., Baer K., Lardi-Studler B., Chudotvorova I., Fritschy J-M., Medina I. and Fuhrer C. Efficient transfection of DNA or shRNA vectors intoneurons using Magnetofection NATURE PROTOCOLS 2007; 2(12): 3090-3101.

Chudotvorova I., Ivanov A., Rama S., Hübner C.A., Pellegrino C., Ben-Ari Y. And Medina I. Early expression of KCC2 in rat hippocampal cultures augments expression of functional GABA synapses. J. Physiol. 2005; 566.3: 671-679.

Couchoux H., Allard B., Legrand C., Jacquemond V. and Berthier C. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells. J. of Physiol. 2007; 580.3: 745–754.

Deleuze V., Chalhoub E., El-Hajj R., Dohet C., Le Clech M., Couraud P-O., Philippe H. and Mathieu D. TAL-1/SCL and Its Partners E47 and LMO2 Up-Regulate VE-Cadherin Expression in Endothelial Cells. Mol. and Cell. Biology 2007; 27 (7): 2687–2697.

Doshida M. et al. Raloxifene Increases Proliferation and Up-regulates Telomerase Activity in Human Umbilical Vein Endothelial Cells. The Journal of Biological Chemistry 2006; 281 (34): 24270-24278.

Eder P., D. Probst, C. Rosker, M. Poteser, H. Wolinski, S.D. Kohlwein, C. Romanin, K. Groschner Phospholipase C-dependent control of cardiac calcium homeostasis involves a TRPC3-NCX1 signaling complex. Cardiovascular Research 2007; 73: 111–119.

Fransen M., Ilse Vastiau, Chantal Brees, Vanessa Brys Guy P. Mannaerts and Paul P. Van Veldhoven. Analysis of Human Pex19p's Domain Structure by Pentapeptide Scanning Mutagenesis. J. Mol. Biol. 2005; 346: 1275–1286.

Fukushima T., Tezuka T., Shimomura T., Nakano S. and Kataoka H. Silencing of Insulin-like Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both Invasiveness and Expression of Progression-associated Gene CD24. J. of Biolog. Chem. 2007; 282 (25): 18634–18644.

Gersting S-W., Schillinger U., Lausier J., Nicklaus P., Rudolph C., Plank C., Reinhardt D. and Rosenecker J. Gene delivery to respiratory epithelial cells by magnetofection. J.Gene Medicine 2004; 6: 913-922.

Goulimari P. et al. Gα_12/13 Is Essential for Directed Cell Migration and Localized Rho-Dia1 Function. JBC 2005; 280 (51): 42242-42251.

Guillaud L., Wong R. and Hirokawa N. Disruption of KIF17–Mint1 interaction by CaMKIIdependent phosphorylation: a molecular model of kinesin–cargo release. Nature Cell Biology 2008; 10 (1): 19-29.

Griesenbach U., Duncan M. Geddes and Eric W.F.W. Alton. Advances in cystic fibrosis gene therapy. Current Opinion in Pulmonary Medicine 2004; 10: 542–546.

Hirao K. et al. Targeted gene delivery to human osteosarcoma cells with magnetic cationic liposomes under a magnetic field Int. J. of Oncology 2003; 22: 1065-1071.

Huth S., Lausier J., Gersting S-W., Rudolph C., Plank C., Welsch U. and Rosenecker J. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J.Gene Medicine 2004; 6: 923-936.

Jahnke A., Hirschberger J., Fischer C., Brill T., Köstlin R., Plank C., Küchenhoff H., Krieger S., Kamenica K. and Schillinger U. Intra-tumoral Gene Delivery of feIL-2, feIFN-c and feGM-CSF using Magnetofection as a Neoadjuvant Treatment Option for Feline Fibrosarcomas: A Phase-I Study. J. Vet. Med. A 2007; 54: 1-8.

Kadota S., Kanayama T., Miyajima N., Takeuchi K. And Nagata K. Enhancing of measles virus infection by magnetofection. J. of Virol. Methods 2005; 128(1-2): 61-66.

Kamau Sarah W. et al. Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acid Research 2006; 34 (5).

Kaneko M., Weiwen Yang, Yoshiki Matsumoto, Fujiko Watt, Keiko Funa. Activity of a novel PDGF β-receptor enhancer during the cell cycle and upon differentiation of neuroblastoma. Experimental Cell Research 2006; 312: 2028-2039.

Kaur S. et al. Robo4 Signaling in Endothelial Cells Implies Attraction Guidance Mechanisms. J. of Biol. Chem. 2006; 281 (16): 11347-11356.

Kim E-A., Yoon Tae Noh, Myung-Jeom Ryu, Hyun-Taek Kim, Sung-Eun Lee, Cheol-Hee Kim, Cheolju Lee, Young Ho Kim and Cheol Yong Choi. Phosphorylation and Transactivation of Pax6 by Homeodomain-interacting Protein Kinase 2. J. of Biolog. Chem. 2006; 281 (11): 7489–7497.

Krötz F., Engelbrecht B., Buerkle MA., Bassermann F., Bridell H., Gloe T., Duyster J., Pohl U. and Sohn HY. The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation. J. Am. Coll. Cardiol. 2005; 45(10): 1700-1706.

Krötz F., Son HY., Gloe T., Planck C. Magnetofection Potentiates Gene Delivery to Cultured Endothelial. Journal of Vascular Research 2003; 40: 425-434.

Krötz F., Wit C., Sohn HY., Zahler S., Gloe T., Pohl U. and Plank C. Magnetofection-A highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol. Ther. May 2003; 7(5): 700-710.

Kumbrink J., Gerlinger M. and Johnson J. P. Egr-1 Induces the Expression of Its Corepressor Nab2 by Activation of the Nab2 Promoter Thereby Establishing a Negative Feedback Loop. JBC 2005; 280 (52): 42785-42793.

Lardi-Studler B., Smolinsky B., Petitjean C.M., Koenig F., Sidler C., Meier J.C., Fritschyl J-M. and Schwarz G. Vertebrate-specific sequences in the gephyrin E-domain regulate cytosolic aggregation and postsynaptic clustering. Journal of Cell Science 2007; 120: 1371-1382.

Lartigue G., Dimaline R., Varro A. and Dockray G.J. Cocaine- and Amphetamine-Regulated Transcript: Stimulation of Expression in Rat Vagal Afferent Neurons by Cholecystokinin and Suppression by Ghrelin. The Journal of Neuroscience 2007; 27(11): 2876 –2882.

Lee C. H., Kim E. J., Jeon K., Tae J. C., Lee K. S., Kim Y. O., Jeong M.-Y., C.-W. Yun et. al. Simple, Efficient, and Reproducible Gene Transfection of Mouse Embryonic Stem Cells by Magnetofection. Stem Cells and Development 2008; 17:133–141.

Liman J. et al. Interaction of BAG1 and Hsp70 Mediates Neuroprotectivity and Increases Chaprone Activity. Mol. and Cell. Biology 2005; 25 (9): 3715-3725.

McCAIG C et al. The Role of Matrix Metalloproteinase-7 in Redefining the astric Microenvironment in Response to Helicobacter pylori. Gastroenterology 2006; 130:1754–1763.

Minami R., Yamamoto M., Takahama S., Miyamura T., Watanabe H., Suematsu E. RCAS1 induced by HIV-Tat is involved in the apoptosis of HIV-1 infected and uninfected CD4+ T cells. Cellular Immunology 2006; 243: 41–47.

Mizutani C. et al. Mechanisms of establishment of persistent SARS-CoV-infected cells. Biochemical and Biophysical Research Communications 2006; 347: 261-265.

Mizutani C. et al. Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells. FEMS Immunol Med Microbiol 2006; 46: 236-243.

Mukai H.Y., Motohashi H., Ohneda O., Suzuki N., Nagano M. and Yamamoto M. Transgene Insertion in Proximity to the c-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation. Mol. and Cell. Biology 2006; 26 (21): 7953–7965.

Mykhaylyka O., Vlaskoua D., Tresilwised N., Pithayanukul P, Möller W., Plank C. Magnetic nanoparticle formulations for DNA and siRNA delivery. J.of Magnetism and Magnetic Materials 2007; 311: 275–281.

Mykhaylyk O., Antequera Y.S., Vlaskou D. & Plank Ch. Generation of magnetic nonviral gene transfer agents and Magnetofection in vitro. Nature Protocols 2007; 2(10): 1-21.

Nagata D., Takahashi M., Sawai K., Tagami T., Usui T., Shimatsu A., Hirata Y., Naruse M. Molecular Mechanism of the Inhibitory Effect of Aldosterone on Endothelial NO Synthase Activity. Hypertension 2006; 48: 165-171.

Pasder O. et al. Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells. Oncogene 2006; 25: 4194-4206.

Pinto M.P., Grou C.P., Alencastre I.S., Oliveira M.E., Miranda C.S., Fransen M. and Azevedo J.E. The Import Competence of a Peroxisomal Membrane Protein Is Determined by Pex19p before the Docking Step. The J. of Biolog. Chem. 2006; 281(45): 34492–34502.

Plank C., Schillinger U., Scherer F., Bergemann C., Remy J.-S., Krötz F., Anton M., Lausier J. and Rosenecker J. The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery. Biol. Chem. May 2003; 384: 737-747.

Plank C., Anton M., Rudolph C., Rosenecker J. and Krötz F. Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opinion on Biological Therapy 2003; 3: 745-758.

Plank C., Scherer F., Schillinger U., Bergemann C., Anton M. Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields. J. Liposome Res. 2003; 13(1): 29-32.

Plank C., Scherer F., Schillinger U., Anton M. Magnetofection: Enhancement and localization of gene delivery with magnetic particles under influence of a magnetic fields. J. Gene Med. 2000; 2((5) Suppl.): S24.

Plank C. Magnetofection: enhancing and targeting gene delivery with lipid-DNA vectors by magnetic force. J. Liposome Res. 2003; 13(1): 105-106.

Rashmi K. Ambasta, Pravir Kumar et al. Direct Interaction of the Novel Nox Proteins with p22phox Is required for the Formation of a Functionally Active NADPH Oxidase. J. of Biological Chem. 2004; 279 (44): 45935-45941.

Recklies A.D., Hua Ling, Chantal White, and Suzanne M. Bernier. Inflammatory Cytokines Induce Production of CHI3L1 by articular Chondrocytes J. of Biol. Chem. 2005; 280 (50): 41213-41221.

Romero D. G., Welsh B.L., Gomez-Sanchez E.P., Yanes L.L., Rilli S. and Gomez-Sanchez C.E. Angiotensin II-Mediated Protein Kinase D Activation Stimulates Aldosterone and Cortisol Secretion in H295R Human Adrenocortical Cells. Endocrinology 2006; 147(12): 6046–6055.

Romero D.G., Yanes L.L., de Rodriguez A.F., Plonczynski M.W., Welsh B.L., Reckelhoff J.F., Gomez-Sanchez E.P. and Gomez-Sanchez C.E. Disabled-2 (Dab2) is Expressed in Adrenal Zona Glomerulosa and is Involved in Aldosterone Secretion. Endocrinology 2007, First published ahead of print February 15, 2007 as doi:10.1210/en. 2006-1509.

Romero D.G., Rilli S., Plonczynski M.W., Yanes L.L., Zhou M.Y., Gomez-Sanchez E.P. and Gomez-Sanchez C.E. Adrenal transcription regulatory genes modulated by angiotensin II and their role in steroidogenesis. Physiol. Genomics 2007; 30: 26–34.

Sacha J.B., Chung C., Rakasz E.G., Spencer S.P., Jonas A.K., Bean A.T., Lee W., Burwitz B.J., Stephany J.J., Loffredo J.T, Allison D.B., Adnan S., Hoji A., Wilson N.A., Friedrich T.C., Lifson J.D., Yang O.O. and Watkins D.I. Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression. The Journal of Immunology 2007; 178: 2746–2754.

Sapet C., Simoncini S., Loriod B., Puthier D., Sampol J., Nguyen C., Dignat-George F. and Anfosso F. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006; 108: 1868-1876.

Schäfer C., Hoffmann L., Heldt K., Reza M., Lornejad-Schäfer, Brauers G., Gehrmann T., Garrow T.A., Häussinger D., Mayatepek E., Schwahn B.C. and Schliess F. Osmotic regulation of betaine homocysteine-S-methyltransferase expression in H4IIE rat hepatoma cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 292:1089-1098.

Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Krüger A., Gänsbacher B. and Plank C. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Therapy 2002; 9: 102-109.

Seki T., Irie N., Nakamura K., Sakaue H., Ogawa W., Kasuga M., Yamamoto H., Ohmori S., Saito N. and Sakai N. Fused protein of δPKC activation loop and PDK1-interacting fragment (δAL-PIF) functions as a pseudosubstrate and an inhibitory molecule for PDK1 when expressed in cells. Genes to Cells 2006; 11: 1051–1070.

Steele I.A., Rod Dimaline R., Pritchard D.M., Peek Jr. R.M., Wang T.C., Dockray G.J. and Varro A. Helicobacter and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 293: G347–G354.

Thomas J.A., Ott D.E. and Gorelick R.J. Efficiency of Human Immunodeficiency Virus Type 1 Postentry Infection Processes: Evidence against Disproportionate Numbers of Defective Virions. Journal of Virology 2007; 81 (8): 4367–4370.

Uchida Y. et al. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease Genes to Cells 2005; 10: 165-179.

Ulrike Schillinger et al. Advances in magnetofection-magnetically guided nucleic acid delivery. Journal of Magnetism and Magnetic Materials 2005; 293: 501-508.

Varro A., Kenny S., Hemers E., McCaig C., Przemeck S., Wang T.C., Bodger K. and Pritchard D.M. Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signalling. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 292: G1133–G1140.

Wang J., Zhang Y, Wei J., Zhang X., Zhang B., Zhu Z., Zou W., Wang Y., Mou Z., Ni B. and Wu Y. Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response. Immunology 2006; 121: 174–182.

Wei W., Xu C., Wu H. Magnetic Iron Oxide Nanoparticles Mediated Gene Therapy for Breast Cancer - An In Vitro Study. Journal of Huazhong University of Science and Technology (Med. Sci.) 2006; 26 (6): 728-730.

Xenariou S. et al. Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Therapy 2006; 1-8.

Yim H-J., Kim H-J., Ko J-H., Cho Y-E., Kim S-M., Kim J-Y., Lee S. and Park J-H. The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death. Cell Death and Differentiation 2007; 1-8.

References - Biomagnetic Separation / Detection

Asgar E., Büssow K., Oster J., Sieper J., Thiel A., Duchmann R. and Adam T. Homologous high-throughput expression and purification of highly conserved E coli proteins. Microbial Cell Factories 2007; 6:18. [purification of endotoxins from protein solution]

Babincova M., Altanerova V., Altaner C., Bergemann C. and Babinec P. In Vitro Analysis of Cisplatin Functionalized Magnetic Nanoparticles in Combined Cancer Chemotherapy and Electromagnetic Hyperthermia. IEEE Transactions on Nanobioscience, 2008; 7(1): 15-19.

Bergemann C., Müller-Schulte D., Oster J., Brassard L., Lübbe A.S. Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications. J. of Magnetism and Magnetic Materials 1999; 194: 45-52.

Brizzolara R.A. and Stamper D.M. The effect of covalent surface immobilization on the bactericidal efficacy of a quaternary ammonium compound. Surf. Interface Anal. 2007; 39: 559–566.

Bryant H.C., Sergatskov D.A., Lovato D., Adolphi N.L., Larson R.S. and Flynn E.R. Magnetic needles and superparamagnetic cells. Phys. Med. Biol. 2007; 52: 4009-4025.

Deponte S., Steingroewer J., Löser C., Boschke E. and Bley T. Biomagnetic separation of Escherichia coli by use of anion-exchange beads: measurement and modeling of the kinetics of cell-bead interactions. Anal. Bioanal. Chem. 2004; 379: 419-426.

Eberbeck D., Bergemann C., Hartwig S., Steinhoff U. and Trahms L. Binding kinetics of magnetic nanoparticles on latex beads studied by magnetorelaxometry. Appl. Organometal. Chem. 2004; 18: 542-547.

Eberbeck D., Bergemann C., Hartwig S., Steinhoff U. and Trahms L. Binding kinetics of magnetic nanoparticles on latex beads and yeast cells studied by magnetorelaxometry. J. of Magnetism and Magnetic Materials 2005; 289: 435-438.

Eberbeck D., Wiekhorst F., Steinhoff U. and Trahms L. Aggregation behaviour of magnetic nanoparticle suspensions investigated by magnetorelaxometry. J. Phys.: Condens. Matter 2006; 18: 2829-2846.

Flynn E. R. and Bryant H.C. A biomagnetic system for in vivo cancer imaging. Phys. Med. Biol. 2005; 50: 1273-1293.

Flynn E.R., Bryant H.C., Bergemann Ch. et al. Use of a SQUID array to detect T-cells with magnetic nanoparticles in determining transplant rejection. J. Magnetism Magnet. Materials 2007; 311: 429-435.

Franzreb M., Siemann-Herzberg M., Hobley T.J. and Thomas R.T. O. Protein purification using magnetic adsorbent particles. Appl. Microbiol. Biotechnol. 2006; 70: 505–516.

Frenzel A., Bergemann C., Köhl G., Reinard T. Novel purification system for 6xHis-tagged proteins by magnetic affinity separation. J. Chromatography B 2003; 793: 325-329.

Hillel Haim, Israel Steiner and Amos Panet. Time Frames for Neutralization during the Human Immunodeficiency Virus Type 1 Entry Phase, as Monitored in Synchronously Infected Cell Cultures. J. of Virology 2005; 79 (1): 622-625.

Hillel Haim, Israel Steiner and Amos Panet. Synchronized Infection of Cell Cultures by Magnetically Controlled Virus. J. of Virology 2007; 81 (7): 3525-3534.

Issle J. and Hartmann U. Scanning force microscopy on spatially and temporally varying magnetic substrates for cell cultivation. Journal of Physics: Conference Series 61 (2007) 487–491.

Jörg Neumann and Ralf Brinkmann. Boiling nucleation on melanosomes and microbeads transiently heated by nanosecond and microsecond laser pulses. Journal of Biomedical Optics 2005; 10(2): 024001-1 - 024001-12.

Jörg Neumann and Ralf Brinkmann. Nucleation and dynamics of bubbles forming around laser heated microabsorbers. Therapeutic Laser Applications and Laser-Tissue Interactions II 2005; Proc. SPIE Vol. 5863.

Korecká L., Jankovicová B., Krenková J., Hernychová L., Slováková M., Le-Nell A., Chmelik J., Foret F., Viovy J-L., Bilková Z. Bioaffinity magnetic reactor for peptide digestion followed by analysis using bottom-up shotgun proteomics strategy. J. Sep. Sci. 2008; 31: 507 – 515.

Ludwig F., Heim E. and Schilling M. Characterization of superparamagnetic nanoparticles by analyzing the magnetization and relaxation dynamics using fluxgate magnetometers. J. of Applied Physics 2007; 101: (113909) 1 – 10.

Prikryl P., Horak D., Ticha M. and Kucerova Z. Magnetic IDA-modified hydrophilic methacrylatebased polymer microspheres for IMAC protein separation. J. Sep. Sci. 2006;29, 2541–2549

Sellaro T. L., Ravindra A. K., Stolz D. B. and Badylak S. Maintenance of Hepatic Sinusoidal Endothelial Cell Phenotype In Vitro Using Organ-Specific Extracellular Matrix Scaffolds. Tissue Engineering 2007; 13(9): 2301-2310.

Sieben S., Bergemann C., Lübbe A.S., Brockmann B., Rescheleit D. Comparison of different particles and methods for magnetic isolation of circulating tumor cells. J. of Magnetism and Magnetic Materials 2001; 225: 175-179.

Steingroewer J., Bley T., Bergemann Ch. and Boschke E. Biomagnetic separation of Salmonella Typhimurium with affine and specific ligand peptides isolated by phage display technique. J. Magnetism Magnet. Materials 2007; 311: 295-299.

Villanueva J., Philip J., Entenberg D., Chaparro C. A., Tanwar M. K., Holland E. C. and Tempst P. Serum Peptide Profiling by Magnetic Particle-Assisted, Automated Sample Processing and MALDI-TOF Mass Spectrometry. Anal. Chem. 2004; 76: 1560-1570.

Villanueva J., Philip J., Chaparro C.A., Li Y., Toledo-Crow R., DeNoyer L., Fleisher M., Robbins R.J. and Tempst P. Correcting Common Errors in Identifying Cancer-Specific Serum Peptide Signatures. J. of Proteome Research 2005; 4: 1060-1072.

References - MRI Imaging

Hilger I., Hofmann F., Reichenbach J.R., Bergemann C., Hiergeist R., Andrä W., Hergt R., Kaiser W.A. In vitro imaging of magnetite particles. RöFo 2001; Band: 173.

Kettering M. et al. Magnetically Based Enhancement of Nanoparticle Uptake in Tumor Cells: Combination of Magnetically Induced Cell Labeling and Magnetic Heating. Fortschr. Röntgenstr. 2006; 178: 1255-1260.

Kettering M. et al. Magnetic nanoparticles as bimodal tools in magnetically induced labelling and magnetic heating of tumour cells: an in vitro study. Nanotechnology 2007; 18: 175101 (9pp)

Lind K., Kresse M., Debus N. P. and Müller R. H. A Novel Formulation for Superparamagnetic Iron Oxide (SPIO) Particles Enhancing MR Lymphography: Comparison of Physicochemical Properties and The in vivo Behaviour. J. Drug Targeting 2002; 10 (3): 221-230.

Lind K., Kresse M., Müller R. Comparison of protein adsorption patterns onto differently charged hydrophilic superparamagnetic iron oxide particles obtained in vitro and ex vivo. Electrophoresis 2001; 22: 3514-3521.